Permits and Restrictions |
View Permits |
---|---|
Organism | Homo sapiens, human |
Tissue | urinary bladder |
Product Format | frozen |
Morphology | epithelial |
Culture Properties | adherent |
Biosafety Level |
1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
Disease | grade IV transitional cell carcinoma |
Age | 67 years |
Gender | female |
Storage Conditions | liquid nitrogen vapor phase |
Karyotype | (P12 and 35) hypotetraploid with marker chromosomes |
---|---|
Derivation | The TCCSUP line was isolated in 1974 from an anaplastic transitional cell carcinoma (TCC) in the neck of the urinary bladder. |
Clinical Data | female |
Antigen Expression | HLA 2, 3, 7, 12 |
Comments |
The patient had a 4 month history of hematuria prior to removal of the tumor. Metastases to the bone marrow were discovered later. Studies on ultrastructure indicated presence of microvilli and lipid bodies but no desmosomes were observed. |
Complete Growth Medium | Minimum essential medium (Eagle) in Earle's BSS with non-essential amino acids (ATCC 30-2003) and 1 mM sodium pyruvate, 90%; fetal bovine serum, 10% |
---|---|
Subculturing |
Medium Renewal: 2 to 3 times per week Protocol: Volumes used in this protocol are for 75 cm2 flasks; proportionally reduce or increase amount of dissociation medium for culture vessels of other sizes. |
Cryopreservation | Culture medium, 95%; DMSO, 5% |
Culture Conditions | Atmosphere: air, 95%; carbon dioxide (CO2), 5% Temperature: 37°C |
STR Profile | Amelogenin: X CSF1PO: 10 D13S317: 11,14 D16S539: 9,11 D5S818: 12 D7S820: 8,9 THO1: 6,9.3 TPOX: 8 vWA: 14,16 |
---|---|
Isoenzymes | AK-1, 1-2 ES-D, 1 G6PD, B GLO-I, 1-2 Me-2, 1 PGM1, 2 PGM3, 1 |
Name of Depositor | C O'Toole |
---|---|
References |
O'Toole CHuman bladder cancer lines: HLA Class I and Class II antigen expression and susceptibility to cytostatic and cytotoxic effects in vitroIn: O'Toole CIn vitro models for cancer researchvol. IVBoca Raton, FLCRC Presspp. 103-125. Fogh J. Cultivation, characterization, and identification of human tumor cells with emphasis on kidney, testis, and bladder tumors. Natl. Cancer Inst. Monogr. 49: 5-9, 1978. PubMed: 571047 Bellet D, et al. Malignant transformation of nontrophoblastic cells is associated with the expression of chorionic gonadotropin beta genes normally transcribed in trophoblastic cells. Cancer Res. 57: 516-523, 1997. PubMed: 9012484 Nayak SK, et al. A cell line from an anaplastic transitional cell carcinoma of human urinary bladder. Br. J. Cancer 35: 142-151, 1977. PubMed: 836756 |
Permits |
These permits may be required for shipping this product to Australia:
|
---|---|
Basic Documentation | Product Sheet Certificate of Analysis SDS |
Other Documentation | Cancer cell line mutation data |
References |
O'Toole CHuman bladder cancer lines: HLA Class I and Class II antigen expression and susceptibility to cytostatic and cytotoxic effects in vitroIn: O'Toole CIn vitro models for cancer researchvol. IVBoca Raton, FLCRC Presspp. 103-125. Fogh J. Cultivation, characterization, and identification of human tumor cells with emphasis on kidney, testis, and bladder tumors. Natl. Cancer Inst. Monogr. 49: 5-9, 1978. PubMed: 571047 Bellet D, et al. Malignant transformation of nontrophoblastic cells is associated with the expression of chorionic gonadotropin beta genes normally transcribed in trophoblastic cells. Cancer Res. 57: 516-523, 1997. PubMed: 9012484 Nayak SK, et al. A cell line from an anaplastic transitional cell carcinoma of human urinary bladder. Br. J. Cancer 35: 142-151, 1977. PubMed: 836756 |